Abbott named to Dow Jones Sustainability Indexes for seventh consecutive year
Receives recognition of leading corporate citizenship performance.
Abbott announced that it was included on both the Dow Jones Sustainability World Index and North America Index for the seventh consecutive year. The Dow Jones Sustainability Indexes (DJSI) recognize the leading companies in each industry sector for responsible economic, environmental and social performance.
Abbott was named the pharmaceutical industry leader in several categories, receiving a score of 100 percent in environmental management and climate strategy, key areas of focus in the company's comprehensive effort to safeguard the environment. Abbott also led the industry in risk and crisis management, stakeholder engagement, standards for suppliers, corporate governance, and occupational health and safety.
Abbott said it is one of only two US-headquartered companies in its industry sector to be listed on both the North America and World Indexes. The company's overall score of 85 percent is significantly higher than the average score of 53 percent for other companies in the sector.
This year, Abbott achieved its highest-ever total score on the Index, demonstrating an ongoing commitment to continuous improvement in citizenship and sustainability. This included recognition for the company's significant strides in R&D and innovation.
"Now more than ever, responsible businesses have an important role to play in helping to build healthy and thriving communities," said Katherine Pickus, Divisional Vice President, Global Citizenship, Abbott. "The combined financial, social and environmental performance of Abbott demonstrates that our business continues to have a positive impact on the world around us, building on our 123-year legacy."
As a member of the prestigious Dow Jones Sustainability World Index, Abbott is among the top 300 of the 2,500 largest companies worldwide in terms of sustainability. The DJSI annual review considers sustainability leaders from each industry on a global and regional level, and involves thorough analyses of corporate governance, risk management, branding, climate change mitigation, supply chain standards, labor practices and related citizenship issues.
- Share this article
- Got more on this story? Email PharmaAsia
- More About
- PRESS RELEASE
- Abbott





















